Post-meeting Survey


Your feedback is highly appreciated.


1.After this meeting, do you agree that timely initiation of biologic treatment can improve patient’s clinical outcomes e.g., nasal obstruction, discharge, anosmia, polyp size, and asthma symptoms (if any)?
Strongly agreeAgreeNeutralDisagreeStrongly disagree
Strongly agree
Agree
Neutral
Disagree
Strongly disagree

2.After this meeting, what is your view in the position of biologics integrated with sinus surgeries for an optimal treatment of CRSwNP? (Multiple answers)

3.After this meeting, do you agree that interleukin(IL)-5 is an important T2 cytokine to address in patients suffering from recurrent CRS with nasal polyps?
Strongly agreeAgreeNeutralDisagreeStrongly disagree
Strongly agree
Agree
Neutral
Disagree
Strongly disagree

4.What is the best part of the meeting? (Multiple answers)